Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer

September 23, 2022

https://www.globenewswire.com/news-release/2022/09/23/2521696/0/en/Tiziana-Life-Sciences-Announces-Purchase-of-Common-Shares-by-Chief-Medical-Officer.html

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq:TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Matthew Davis, its Chief Medical Officer, purchased 75,000 common shares at $0.83 per share, bringing his total holding to 175,000 common shares.

Read more at globenewswire.com

Related news for (TLSA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.